RESUMO
A 22-year-old miniature horse gelding was brought to a veterinary clinic with multiple porcupine quills embedded in the face. One quill had perforated through the left caudoventral cornea but did not extend beyond the anterior chamber. The horse was referred to a specialist clinic for removal of the intraocular quill and subsequent primary surgical repair of the corneal wound. Following aggressive medical treatment, the horse retained vision.
Piquants de porc-épic oculaires et faciaux chez un cheval miniature. Un cheval hongre miniature de 22 ans a été amené à une clinique vétérinaire avec plusieurs piquants de porc-épic incrustés dans le visage. Un piquant avait perforé la cornée en partie caudo-ventrale gauche mais ne s'étendait pas au-delà de la chambre antérieure de l'oeil. Le cheval a été référé à une clinique spécialisée pour le retrait du piquant intraoculaire et la réparation chirurgicale primaire de la plaie cornéenne. Après un traitement médical agressif, le cheval était toujours capable de voir.(Traduit par Dr Serge Messier).
Assuntos
Porcos-Espinhos , Animais , Cavalos , Hospitais Veterinários , MasculinoRESUMO
Vitreous substitutes are clinically used to maintain retinal apposition and preserve retinal function; yet the most used substitutes are gases and oils which have disadvantages including strict face-down positioning post-surgery and the need for subsequent surgical removal, respectively. We have engineered a vitreous substitute comprised of a novel hyaluronan-oxime crosslinked hydrogel. Hyaluronan, which is naturally abundant in the vitreous of the eye, is chemically modified to crosslink with poly(ethylene glycol)-tetraoxyamine via oxime chemistry to produce a vitreous substitute that has similar physical properties to the native vitreous including refractive index, density and transparency. The oxime hydrogel is cytocompatible in vitro with photoreceptors from mouse retinal explants and biocompatible in rabbit eyes as determined by histology of the inner nuclear layer and photoreceptors in the outer nuclear layer. The ocular pressure in the rabbit eyes was consistent over 56 d, demonstrating limited to no swelling. Our vitreous substitute was stable in vivo over 28 d after which it began to degrade, with approximately 50% loss by day 56. We confirmed that the implanted hydrogel did not impact retina function using electroretinography over 90 days versus eyes injected with balanced saline solution. This new oxime hydrogel provides a significant improvement over the status quo as a vitreous substitute.